Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$595K Hold
3,246
0.02% 661
2025
Q4
$571K Hold
3,246
0.02% 666
2025
Q3
$455K Hold
3,246
0.01% 745
2025
Q2
$408K Buy
3,246
+703
+28% +$87.6K 0.01% 770
2025
Q1
$348K Buy
2,543
+7
+0.3% +$1K 0.01% 794
2024
Q4
$388K Sell
2,536
-4
-0.2% -$675 0.01% 773
2024
Q3
$492K Hold
2,540
0.02% 706
2024
Q2
$589K Sell
2,540
-266
-9% -$57.8K 0.02% 607
2024
Q1
$605K Sell
2,806
-705
-20% -$165K 0.02% 583
2023
Q4
$909K Sell
3,511
-29
-0.8% -$7.12K 0.03% 467
2023
Q3
$910K Sell
3,540
-330
-9% -$88.3K 0.03% 440
2023
Q2
$1.1M Hold
3,870
0.04% 402
2023
Q1
$1.08M Sell
3,870
-18
-0.5% -$4.98K 0.04% 428
2022
Q4
$1.08M Buy
3,888
+437
+13% +$123K 0.04% 439
2022
Q3
$921K Buy
3,451
+30
+0.9% +$6.37K 0.03% 492
2022
Q2
$698K Buy
3,421
+1,097
+47% +$224K 0.03% 583
2022
Q1
$489K Sell
2,324
-1,705
-42% -$371K 0.02% 673
2021
Q4
$967K Sell
4,029
-627
-13% -$161K 0.03% 460
2021
Q3
$1.32M Sell
4,656
-337
-7% -$110K 0.05% 365
2021
Q2
$1.73M Sell
4,993
-282
-5% -$85.4K 0.06% 346
2021
Q1
$1.48M Sell
5,275
-11,241
-68% -$3.03M 0.06% 362
2020
Q4
$4.04M Sell
16,516
-6,356
-28% -$1.64M 0.17% 166
2020
Q3
$6.49M Sell
22,872
-4,652
-17% -$1.3M 0.3% 99
2020
Q2
$7.36M Buy
27,524
+22,797
+482% +$6.85M 0.38% 80
2020
Q1
$1.5M Buy
4,727
+638
+16% +$194K 0.08% 251
2019
Q4
$1.21M Buy
+4,089
New +$1.13M 0.06% 328

Other funds holding BIIB

Vestcor Inc's BIIB Position: Q1 2026 in Review

Vestcor Inc held its Biogen (BIIB) position steady in Q1 2026 at 3,246 shares worth $595K. The position accounts for 0.02% of the portfolio, ranked #661.

Vestcor Inc first reported a position in BIIB in Q4 2019 and has held it in 26 quarters since. The position peaked at $7.36M in Q2 2020. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Vestcor Inc held 3,246 shares of Biogen worth $595K as of Q1 2026.
  • Vestcor Inc left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.02% of Vestcor Inc's portfolio in Q1 2026, its #661 holding.
  • Vestcor Inc first reported a position in Biogen in Q4 2019 and has held it in 26 quarters since.
  • Vestcor Inc's Biogen position peaked at $7.36M in Q2 2020.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.